QQ客服 官方微博 反馈留言

	Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
	Bo, Xiaobo; Wang, Jie; Suo, Tao; Ni, Xiaoling; Liu, Han; Shen, Sheng; Li, Min; Wang, Yueqi; Liu, Houbao; Xu, Jiejie
刊名	BMC CANCER
	2018
卷号	18
关键词	Mast cells Biliary tract cancer Surgery Overall survival Adjuvant chemotherapy
ISSN号	1471-2407
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3607413
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Bo, Xiaobo,Wang, Jie,Suo, Tao,et al. Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients[J]. BMC CANCER,2018,18.
APA	Bo, Xiaobo.,Wang, Jie.,Suo, Tao.,Ni, Xiaoling.,Liu, Han.,...&Xu, Jiejie.(2018).Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients.BMC CANCER,18.
MLA	Bo, Xiaobo,et al."Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients".BMC CANCER 18(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。